Rare diseases
Investigational molecules
Locations
Back to France1 490 clinical trials in Marseille, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Safety and Effects of PTC518 for Patients with Huntington's Disease
FranceStudy of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy
FranceStudy on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury
FranceStudy on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients
FranceStudy of ONCOFID-P-B for Patients with Bladder Carcinoma in Situ Unresponsive to BCG Treatment
FranceStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
FranceStudy on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
FranceStudy Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment
FranceStudy on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis
FranceStudy on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery
FranceStudy on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection
FranceStudy on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
FranceThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on innovative treatments for head and neck squamous cell carcinoma, examining novel therapies and combinations with radiotherapy. Research includes investigations into endometrial cancer and bladder cancer treatments.
Particular emphasis on combining immunotherapy with conventional treatments for improved patient outcomes.
Innovative research addressing heart failure prevention and treatment of acute myocardial infarction. Studies include new approaches for managing hypertriglyceridemia and chronic kidney disease.
Focus on developing novel therapeutic approaches and improving patient outcomes in cardiovascular health.
Clinical investigations into multiple sclerosis treatment strategies and management of essential tremor. Research includes innovative approaches for Dravet Syndrome and neurological disorders.
Emphasis on developing targeted therapies for various neurological conditions affecting both adults and children.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
